A full-spectrum low-THC cannabis extract (NTI-164) significantly reduced microglial inflammation markers and protected neurons from excitotoxic damage in cell models, while CBD alone did not achieve the same anti-inflammatory effects.
Cannabis pharmacology researchers, neuroinflammation researchers, medical cannabis formulators
Full-spectrum extract reduced inflammation; CBD alone did not
What the researchers found
NTI-164, a high-CBD/low-THC full-spectrum extract, significantly attenuated inflammation-induced upregulation of microglial inflammatory markers in BV-2 microglia, while CBD alone did not. NTI-164 also promoted neuron proliferation and survival under excitotoxic conditions in SHSY-5Y neurons.
Why it matters
This study provides direct evidence for the "entourage effect," showing that a whole-plant extract can outperform an isolated cannabinoid. The neuroprotective findings are relevant to conditions like autism spectrum disorder where neuroinflammation plays a role.
The numbers in context
NTI-164 significantly attenuated microglial inflammatory markers; CBD alone did not; NTI-164 promoted neuron proliferation and survival under excitotoxic conditions.
How the study worked
In vitro study using BV-2 microglial cells and SHSY-5Y neurons to compare anti-inflammatory and neuroprotective effects of a full-spectrum cannabis extract (NTI-164) versus CBD alone.
What this study cannot tell us
In vitro study using cell lines, not living brain tissue. Cannot extrapolate directly to human disease. NTI-164 is a specific proprietary extract that may not represent all full-spectrum products.
How to read the evidence
In vitro cell study with controlled comparisons, but no in vivo or human data.
When this study was published
2024 publication
The bigger picture
The debate between isolated CBD and full-spectrum extracts has major implications for medical cannabis formulation. These in vitro results suggest that minor cannabinoids and terpenes in whole-plant extracts may contribute meaningfully to therapeutic effects.
Questions still open
- Which specific minor cannabinoids or terpenes in NTI-164 contribute to its superior anti-inflammatory effects?
- Would these in vitro advantages translate to clinical benefits in neuroinflammatory conditions?
Common questions
Is full-spectrum cannabis better than CBD alone?
Can cannabis extracts protect brain cells?
Read the original research
Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity.
Biomolecules, 14(11)
Citation
Ross-Munro, Emily; Isikgel, Esra; Fleiss, Bobbi. (2024). Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity.. Biomolecules, 14(11). https://doi.org/10.3390/biom14111434
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk